Table 2 Patient disposition (overall and by previous treatment)
Treatment in previous study | |||
|---|---|---|---|
Number (%) | OROS®hydromorphone | CR morphine | Overall |
Entered the study | 35 (100) | 33 (100) | 68 (100) |
Completed the study | 4 (11.4) | 6 (18.2) | 10 (14.7) |
Did not complete study | 31 (88.6) | 27 (81.8) | 58 (85.3) |
Reasons for not completing the study | |||
Death | 10 (28.6) | 5 (15.2) | 15 (22.1) |
Progression of study disease | 7 (20.0) | 7 (21.2) | 14 (20.6) |
Adverse event | 5 (14.3) | 4 (12.1) | 9 (13.2) |
Lack of efficacy | 4 (11.4) | 4 (12.1) | 8 (11.8) |
Protocol violation | 3 (8.6) | 4 (12.1) | 7 (10.3) |
Withdrawal of consent | 1 (2.9) | 2 (6.1) | 3 (4.4) |
Administrative reason | 1 (2.9) | 1 (3.0) | 2 (2.9) |